Sato H - Search Results

1

Inhibition of transporter-mediated hepatic uptake as a mechanism for drug-drug interaction between cerivastatin and cyclosporin A.

Shitara Y, Itoh T, Sato H, Li AP, Sugiyama Y. Shitara Y, et al. Among authors: sato h. J Pharmacol Exp Ther. 2003 Feb;304(2):610-6. doi: 10.1124/jpet.102.041921. J Pharmacol Exp Ther. 2003. PMID: 12538813

2

Gemfibrozil and its glucuronide inhibit the organic anion transporting polypeptide 2 (OATP2/OATP1B1:SLC21A6)-mediated hepatic uptake and CYP2C8-mediated metabolism of cerivastatin: analysis of the mechanism of the clinically relevant drug-drug interaction between cerivastatin and gemfibrozil.

Shitara Y, Hirano M, Sato H, Sugiyama Y. Shitara Y, et al. Among authors: sato h. J Pharmacol Exp Ther. 2004 Oct;311(1):228-36. doi: 10.1124/jpet.104.068536. Epub 2004 Jun 11. J Pharmacol Exp Ther. 2004. PMID: 15194707

3

In vitro and in vivo correlation of the inhibitory effect of cyclosporin A on the transporter-mediated hepatic uptake of cerivastatin in rats.

Shitara Y, Hirano M, Adachi Y, Itoh T, Sato H, Sugiyama Y. Shitara Y, et al. Among authors: sato h. Drug Metab Dispos. 2004 Dec;32(12):1468-75. doi: 10.1124/dmd.32.12.. Drug Metab Dispos. 2004. PMID: 15550721

4

Evaluation of drug-drug interaction in the hepatobiliary and renal transport of drugs.

Shitara Y, Sato H, Sugiyama Y. Shitara Y, et al. Among authors: sato h. Annu Rev Pharmacol Toxicol. 2005;45:689-723. doi: 10.1146/annurev.pharmtox.44.101802.121444. Annu Rev Pharmacol Toxicol. 2005. PMID: 15822193 Review.

5

Effect of aminoguanidine on lipopolysaccharide-induced changes in rat liver transporters and transcription factors.

Aoki K, Nakajima M, Hoshi Y, Saso N, Kato S, Sugiyama Y, Sato H. Aoki K, et al. Among authors: sato h. Biol Pharm Bull. 2008 Mar;31(3):412-20. doi: 10.1248/bpb.31.412. Biol Pharm Bull. 2008. PMID: 18310902 Free article.

6

The quantitative prediction of CYP-mediated drug interaction by physiologically based pharmacokinetic modeling.

Kato M, Shitara Y, Sato H, Yoshisue K, Hirano M, Ikeda T, Sugiyama Y. Kato M, et al. Among authors: sato h. Pharm Res. 2008 Aug;25(8):1891-901. doi: 10.1007/s11095-008-9607-2. Epub 2008 May 16. Pharm Res. 2008. PMID: 18483837

7

Nitric oxide and peroxynitrite regulate transporter transcription in rat liver slices.

Aoki K, Saso N, Kato S, Sugiyama Y, Sato H. Aoki K, et al. Among authors: sato h. Biol Pharm Bull. 2008 Oct;31(10):1882-7. doi: 10.1248/bpb.31.1882. Biol Pharm Bull. 2008. PMID: 18827348 Free article.

8

Potentiation of domperidone-induced catalepsy by a P-glycoprotein inhibitor, cyclosporin A.

Tsujikawa K, Dan Y, Nogawa K, Sato H, Yamada Y, Murakami H, Ohtani H, Sawada Y, Iga T. Tsujikawa K, et al. Among authors: sato h. Biopharm Drug Dispos. 2003 Apr;24(3):105-14. doi: 10.1002/bdd.343. Biopharm Drug Dispos. 2003. PMID: 12673668

9

Inhibitory effect of erythromycin on potassium currents in rat ventricular myocytes in comparison with disopyramide.

Hanada E, Ohtani H, Hirota M, Uemura N, Nakaya H, Kotaki H, Sato H, Yamada Y, Iga T. Hanada E, et al. Among authors: sato h. J Pharm Pharmacol. 2003 Jul;55(7):995-1002. doi: 10.1211/0022357021459. J Pharm Pharmacol. 2003. PMID: 12906757

10

Demonstration of docosahexaenoic acid as a bioavailability enhancer for CYP3A substrates: in vitro and in vivo evidence using cyclosporin in rats.

Hirunpanich V, Katagi J, Sethabouppha B, Sato H. Hirunpanich V, et al. Among authors: sato h. Drug Metab Dispos. 2006 Feb;34(2):305-10. doi: 10.1124/dmd.105.007088. Epub 2005 Nov 18. Drug Metab Dispos. 2006. PMID: 16299163

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10,138 results

Search Page

Filters